Publikationsliste
<< Tilbage
« Forrige
1
2
3
4
5
6
43. Hippe E, Westin J, Wisløff F. Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care. Eur J Haematol 2005; 74: 185-93.
44. Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P. Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes. Eur J Haematol 2005; 75: 293-98.
45. Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Brit J Haematol 2006; 132: 410-51.
46. Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wisløff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Gedde-Dahl T, Hammerstrøm J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL. Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results with focus on the effect of response degree on survival and relapse pattern after transplantation. Haematologica 2006; 91: 1228-33.
47. Lenhoff S, Hjorth M, Westin J, Brinch L, Backström B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerstrøm J, Johnsen HE, Juliusson G, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I. Impact of age on survival after intensive chemotherapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group. Br J Haematol 2006; 133: 389-96
48. Mylin AK, Rasmussen T, Johansen JS, Knudsen LM, Nørgaard PH, Lenhoff S, Dahl IM, Johnsen HE for the Nordic Myeloma Study Group. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur J Haematol 2006; 77: 416-24
49. Wisløff F, Kvam AK, Hjorth M, Lenhoff S. Serum calcium is an independent predictor of quality of life in multiple myeloma. Eur J Haematol, in press.
50. Vangsted A, Gimsing P, Klausen TW, Andersen Nexø B, Wallin H, Andersen P, Hokland P, Lillevang ST, Vogel U. Polymorphisms in the genes ERCC2, XRCC3, and CD3EAP, influence treatment ourcome in multiple myeloma undergoing autologous bone marrow transplantation. Int J Cancer, in press.
Rekvirering